Prevention of nausea and vomiting associated with chemotherapy

Active Ingredient: Aprepitant

Indication for Aprepitant

Population group: only adolescents (12 years - 18 years old)
Therapeutic intent: Preventive action

Prevention nausea and vomiting associated with highly and moderately emetogenic cancer chemotherapy in adolescents from the age of 12.

For this indication, competent medicine agencies globally authorize below treatments:

80-125 mg once daily

Route of admnistration

Oral

Defined daily dose

80 - 125 mg

Dosage regimen

From 80 To 125 mg once every day

Loading dose

125 mg

Maintenance dose

80 mg

Detailed description

Aprepitant is given for 3 days as part of a regimen that includes a 5-HT3 antagonist. The recommended dose of capsules of aprepitant is 125 mg orally on Day 1 and 80 mg orally on Days 2 and 3. Aprepitant is administered orally 1 hour prior to chemotherapy on Days 1, 2 and 3. If no chemotherapy is given on Days 2 and 3, aprepitant should be administered in the morning. If a corticosteroid, such as dexamethasone, is co-administered with aprepitant, the dose of the corticosteroid should be administered at 50% of the usual dose.

The safety and efficacy of the 80 mg and 125 mg capsules have not been demonstrated in children less than 12 years of age. No data are available. Refer to the powder for oral suspension SmPC for appropriate dosing in infants, toddlers and children aged 6 months to less than 12 years.

Active ingredient

Aprepitant

Aprepitant is a selective high-affinity antagonist at human substance P neurokinin 1 (NK1) receptors.

Read more about Aprepitant

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.